Abstract:188 Objectives: Although various types of imaging agents have been developed for photoacoustic (PA) imaging, relatively few imaging agents exhibit high selectivity/sensitivity to the tumor microenvironment for on-demand PA imaging and therapy. Meantime, a common concern about nanoparticles for PA imaging is the nonspecific uptake by mononuclear phagocyte systems (e.g., liver/spleen) and low accumulation in tumors due to the poor enhanced permeability and retention (EPR) effect. Our goal is to develop an intelligent theranostic agent, which can remain as small molecules during circulation in the bloodstream, self-assemble into larger nanostructures in the tumor, and then be activated by the tumor microenvironment for PA imaging-guided tumor therapy. Methods: Herein, we reported molybdenum-based polyoxometalate (POM) clusters with the highest oxidation state of Mo(VI) (denoted as Ox-POM) as novel agents for redox-activated PA imaging-guided photothermal therapy (PTT). Capable of escaping from recognition and capture by the liver and spleen, these renal clearable clusters with ultra-small size can accumulate in the tumor, self-assemble into larger nanoclusters at low pH, and are reduced to near-infrared (NIR) absorptive agents in the tumor microenvironment. Systematic in vitro and in vivo experiments were performed to evaluate their bioresponsive and theranostic capability. Results: These Ox-POMs were highly uniform with their hydrated size increasing from 1.9 nm (pH = 7.4) to 29.3 nm (pH = 6.5) and to ∼0.43 μm at pH 5.0. The clusters showed no NIR absorption in their original chemical form but exhibited strong NIR absorption because Mo(VI) is reduced to Mo(V) when incubated with glutathione (GSH), exhibiting high-performance PA imaging and photothermal conversion in vitro. The PET imaging of 89Zr-Ox-POM results showed these clusters could escape from recognition by the liver and spleen and were mainly excreted through the kidneys, which is highly desirable for reducing the potential toxic effects. Studies in 4T1 tumor-bearing mice indicated that these clusters could be employed for bioresponsive PA imaging-guided tumor ablation in vivo. The PA signal was detected in the tumors as early as 1 h p.i., demonstrating the strong redox-activated effect of Ox-POM by the tumor redox status. The temperature of the tumor rapidly increased to above 40 °C in 30 s and reached 52 °C in 5 min under laser irradiation, and the tumor growth was eliminated without subsequent recurrence for a prolonged period of up to 2 months, whereas the control groups demonstrated rapid tumor growth. CONCLUSION: In summary, we present here the redox-activated Ox-POM clusters for tumor microenvironment-responsive PA imaging-guided tumor ablation. Importantly, these bioresponsive clusters with long in vivo circulation half-life can be passively accumulated in the tumor, self-assemble into larger nanosizes under the tumor’s acidic environment, and be reduced to NIR absorptive agents for efficient PA imaging-guided PTT of cancer. As a proof-of-concept, this finding is expected to establish a new class of redox-activated probes based on clusters, bridging the conventional concepts of “molecule” and “nano” in the bioimaging field.

Metallic 1T Phase Enabling MoS 2 Nanodots as an Efficient Agent for Photoacoustic Imaging Guided Photothermal Therapy in the Near‐Infrared‐II Window

1T-Phase Dirac Semimetal PdTe 2 Nanoparticles for Efficient Photothermal Therapy in the NIR-II Biowindow

Photodynamic Therapy: when Van Der Waals Heterojunction Meets Tumor

Multicomponent Transition Metal Dichalcogenide Nanosheets for Imaging‐Guided Photothermal and Chemodynamic Therapy

Metallic phase enabling MoS2 nanosheets as an efficient sonosensitizer for photothermal-enhanced sonodynamic antibacterial therapy

Visible Light–Near-Infrared Photodetection on Cys-MoO3−x Nanoparticles for Photothermal Therapy against Papillary Thyroid Carcinoma

Ultrathin Cu-TCPP MOF nanosheets: a new theragnostic nanoplatform with magnetic resonance/near-infrared thermal imaging for synergistic phototherapy of cancers

MoS 2 -based nanocomposites with high photothermal conversion efficiency for combinational photothermal/photodynamic tumor therapy

Intercalating of AIEgens into MoS 2 nanosheets to induce crystal phase transform for enhanced photothermal and photodynamic synergetic anti-tumor therapy

Ultrathin carbon layer coated MoO2 nanoparticles for high-performance near-infrared photothermal cancer therapy

Hybrid MoSe2-indocyanine Green Nanosheets As a Highly Efficient Phototheranostic Agent for Photoacoustic Imaging Guided Photothermal Cancer Therapy.

A simple POM clusters for in vivo NIR-II photoacoustic imaging-guided NIR-II photothermal therapy

Ultrathin Two‐Dimensional Plasmonic PtAg Nanosheets for Broadband Phototheranostics in Both NIR‐I and NIR‐II Biowindows

Phase and Defect Engineering of MoSe 2 Nanosheets for Enhanced NIR-II Photothermal Immunotherapy

Phase and Defect Engineering of MoSe2 Nanosheets for Enhanced NIR-II Photothermal Immunotherapy.

Hydrogen Sulfide Dual-Activated NIR-II Photoacoustic Probes for Accurate Imaging and Efficient Photothermal Therapy of Colon Cancer

Binary Pt/Te Nanoheterostructures with High Photothermal Conversion Efficiency and Anti-inflammatory Action for Enhanced Photothermal Therapy of 4T1 Breast Tumors Guided by Photoacoustic Imaging

MoO3-x nanosheets-based platform for single NIR laser induced efficient PDT/PTT of cancer

Engineering Two-dimensional tungsten-doped molybdenum selenide transformed conformational nanoarchitectonics: Trimodal therapeutic nanoagents for enhanced synergistic Photothermal/Chemodynamic/Chemotherapy of breast carcinoma

Atomic-Level Nanorings (A-Nrs) Therapeutic Agent for Photoacoustic Imaging and Photothermal/Photodynamic Therapy of Cancer

Redox-Activated Photoacoustic Imaging-Guided Photothermal Therapy with Bioresponsive Polyoxometalate Cluster